Alasdair Milton

Alasdair Milton is a managing director in KPMG's healthcare and life sciences strategy practice with over 20 years of experience. He leads the precision medicine offering, with a particular focus in cell and gene therapies. As a trained cancer biologist, he helps clients solve complex business problems that require deep scientific and technical knowledge, and has worked across a multitude of therapeutic areas.